video
Latanoprost For Glaucoma Treatment

Latanoprost For Glaucoma Treatment

Latanoprost is a highly effective prostaglandin analog ophthalmic drug widely used to reduce intraocular pressure (IOP) in patients with glaucoma and ocular hypertension. It works by improving the natural outflow of aqueous humor from the eye. Latanoprost is well-tolerated by most patients and is typically administered once daily for consistent and long-lasting IOP control.

Product Introduction

Latanoprost API

High-Performance Prostaglandin Analog for Ophthalmic Development

A prostaglandin analog eye drop called latanoprost is used to reduce increased intraocular pressure in diseases such ocular hypertension and open-angle glaucoma. It allows for once-daily dosage with generally acceptable tolerance and few systemic side effects by enhancing the outflow of aqueous humor through the uveoscleral channel. Latanoprost's ability to lower intraocular pressure and enhance long-term glaucoma management has made it a first-line treatment.

Product Overview

When development teams source Latanoprost, the main concern is rarely the chemical name itself, but how consistently the material performs during formulation and stability testing. This product is supplied for that exact purpose: to support reproducible development of glaucoma therapies where prostaglandin analogues are sensitive to light, temperature and solvent systems.

Instead of positioning this material as a finished solution, it is offered as a controlled, well-documented raw input that allows formulation scientists and QC teams to work with predictable variables from the outset.

Identity and Core Parameters

  • ▸ CAS Number: 130209-82-4
  • ▸ Molecular Formula: C₂₆H₄₀O₅
  • ▸ Molecular Weight: ~432.59 g/mol
  • ▸ Physical State: Pale yellow to clear oil or semi-solid
  • ▸ Assay / Purity: ≥ 98% by HPLC (lot-specific)
  • ▸ Chemical Class: Prostaglandin F₂α analogue
  • ▸ Intended Use: Pharmaceutical development and manufacturing input

Each batch is released only after analytical confirmation of identity and purity, documented in the COA.

Why Formulation Teams Choose This Supply

  • ▸ Predictable handling behavior: Stable performance under light-protected and low-temperature conditions.
  • ▸ Controlled impurity profile: Degradation trends are monitored per batch for internal criteria assessment.
  • ▸ Suitable for ophthalmic workflows: Critical for low-dose accuracy and chemical stability in IOP-lowering products.
  • ▸ Consistent batch-to-batch quality: Designed to minimize variability and avoid method re-validation.

Storage, Handling & Transport

Storage: Short-term at 2–8 °C; Long-term at –20 °C recommended. Minimize light and moisture exposure.

Handling: Best handled under subdued light using specified solvent systems; avoid temperature cycling.

Transport: Packed in moisture-barrier containers with cold-chain shipping options available.

Documentation & Regulatory Support

Every shipment includes documentation required for supplier qualification:

  • Certificate of Analysis (COA)
  • MSDS / TDS
  • ▸Batch traceability information
  • Stability or impurity summaries (available on request)

Ordering and Supply Model

  • Evaluation quantities available for laboratory validation.
  • Scalable supply for pilot or commercial manufacturing.
  • Adaptable packaging and labeling for production workflows.
  • Long-term supply alignment with production forecasts.

Frequently Asked Questions

Q: Is this material suitable for finished drug use?

A: No. It is supplied as a pharmaceutical raw material for formulation, development and manufacturing purposes only.

Q: Can we request analytical data beyond the standard COA?

A: Yes. Additional impurity or stability data can be provided to support internal validation or regulatory review.

Q: How should incoming batches be qualified?

A: We recommend confirming identity and assay against your internal reference standards using the supplied COA as a baseline.

B2B Supply Reliability

 

A flexible approach allows development teams to progress with chemical integrity and regulatory confidence.

Hot Tags: latanoprost for glaucoma treatment, China latanoprost for glaucoma treatment manufacturers, suppliers, factory, 32233-40-2, Carboprost Trometamina, Human APIs, 155206-00-1, 39746-00-4, 130209-82-4

Send Inquiry

whatsapp

Phone

VK

Inquiry

Bag